GILD
Price:
$93.95
Market Cap:
$117.09B
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, an injection for intravenous use, for the treatment of coronavirus disease 2019; and Epclusa, Harvoni, Vosevi, Vemlidy, and Viread for the treatment of liver diseases. It also offers Yescarta, Tecartus, Trodelvy, and Zydelig products for the treatment of hematology, oncology, and cell therapy patients. In addition, the company provides Letairis, an ora...[Read more]
Industry
Drug Manufacturers - General
IPO Date
1992-01-22
Stock Exchange
NASDAQ
Ticker
GILD
According to Gilead Sciences, Inc.’s latest financial reports and current stock price. The company's current PE Ratio is 1.04K. This represents a change of 8.91% compared to the average of 11.59 of the last 4 quarters.
The mean historical PE Ratio of Gilead Sciences, Inc. over the last ten years is 95.64. The current 1.04K PE Ratio has changed 109.05% with respect to the historical average. Over the past ten years (40 quarters), GILD's PE Ratio was at its highest in in the December 2018 quarter at 6.72K. The PE Ratio was at its lowest in in the September 2019 quarter at -17.22.
Average
95.64
Median
15.10
Minimum
7.10
Maximum
822.84
Discovering the peaks and valleys of Gilead Sciences, Inc. PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 5.27%
Maximum Annual PE Ratio = 822.84
Minimum Annual Increase = -98.22%
Minimum Annual PE Ratio = 7.10
Year | PE Ratio | Change |
---|---|---|
2023 | 17.85 | -23.94% |
2022 | 23.46 | 60.15% |
2021 | 14.65 | -98.22% |
2020 | 822.84 | 5.27% |
2019 | 15.32 | 2.95% |
2018 | 14.88 | -26.44% |
2017 | 20.23 | 184.87% |
2016 | 7.10 | -13.19% |
2015 | 8.18 | -30.99% |
2014 | 11.86 | -68.25% |
The current PE Ratio of Gilead Sciences, Inc. (GILD) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages
3-year avg
18.65
5-year avg
178.82
10-year avg
95.64
Gilead Sciences, Inc.’s PE Ratio is greater than Amgen Inc. (33.58), greater than Merck & Co., Inc. (20.73), greater than AbbVie Inc. (62.10), greater than Johnson & Johnson (23.91), greater than Bristol-Myers Squibb Company (-16.14), greater than Pfizer Inc. (35.53), greater than Eli Lilly and Company (85.65), greater than AstraZeneca PLC (31.34),
Company | PE Ratio | Market cap |
---|---|---|
33.58 | $142.17B | |
20.73 | $251.57B | |
62.10 | $317.73B | |
23.91 | $351.15B | |
-16.14 | $117.15B | |
35.53 | $151.34B | |
85.65 | $755.34B | |
31.34 | $205.57B |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Gilead Sciences, Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Gilead Sciences, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the PE Ratio?
How can you use the PE Ratio?
What is Gilead Sciences, Inc.'s PE Ratio?
How is the PE Ratio calculated for Gilead Sciences, Inc. (GILD)?
What is the highest PE Ratio for Gilead Sciences, Inc. (GILD)?
What is the 3-year average PE Ratio for Gilead Sciences, Inc. (GILD)?
What is the 5-year average PE Ratio for Gilead Sciences, Inc. (GILD)?
How does the current PE Ratio for Gilead Sciences, Inc. (GILD) compare to its historical average?